7487 Results

People

  1. Brennan
    Brennan
  2. Danishefsky
    Danishefsky
  3. Larson
    Larson
  4. Scheinberg
    Scheinberg
  5. Fuks
    Fuks
  6. Rosen
    Rosen
  7. Hricak
    Hricak
  8. Pasternak
    Pasternak
  9. Sadelain
    Sadelain
  10. Scardino
    Scardino

Groups

  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)
  7. Radiology, Department of (1814)
  8. Hematologic Malignancies Research (1617)
  9. Hematologic Malignancies, Division of (1517)
  10. Center for Molecular Imaging and Biotechnology (1340)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Journal Article (4957)
  2. Meeting Abstract (2007)
  3. Book Section (216)
  4. Conference Paper (122)
  5. Review (79)
  6. Editorial (48)
  7. Book Whole (28)
  8. Research Letter (15)
  9. Correspondence (8)
  10. Miscellaneous (6)
  11. Guidelines (1)
Groups
  1. Molecular Pharmacology and Chemistry Program Faculty (7487)
  2. Sloan Kettering Institute Faculty (7487)
  3. GSK Faculty (4697)
  4. Department of Medicine (2717)
  5. Surgery (2096)
  6. Center for Hematologic Malignancies (1819)

More Groups

People
  1. Murray Brennan (1059)
  2. Steven Larson (957)
  3. Peter Scardino (671)
  4. Michel Sadelain (582)
  5. Samuel Danishefsky (539)
  6. David Scheinberg (499)

More People

Years
  1. 2025 (36)
  2. 2024 (94)
  3. 2023 (122)
  4. 2022 (150)
  5. 2021 (154)
  6. 2020 (162)

More Years

Publications
  1. Journal of Nuclear Medicine (382)
  2. Blood (379)
  3. Cancer Research (340)
  4. Journal of Clinical Oncology (315)
  5. Annals of Surgical Oncology (181)
  6. International Journal of Radiation Oncology, Biology, Physics (176)

More Publications

Publishers
  1. American Association for Cancer Research (712)
  2. Elsevier Inc. (693)
  3. Nature Publishing Group (490)
  4. Springer (467)
  5. American Chemical Society (440)
  6. Elsevier Science, Inc. (405)

More Publishers

Results (7487)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions
    Journal Article

    Bradbury, M. S.; Phillips, E.; Montero, P. H.; Cheal, S. M.; Stambuk, H.; Durack, J. C.; Sofocleous, C. T.; Meester, R. J. C.; Wiesner, U.; Patel, S.
    Integrative Biology (2013)

    Fulltext@MSK | Save
  • Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
    Journal Article

    Ahmad, I.; Singh, L. B.; Yang, Z. H.; Kalna, G.; Fleming, J.; Fisher, G.; Cooper, C.; Cuzick, J.; Berney, D. M.; Møller, H.; more...
    British Journal of Cancer (2013)

    Fulltext@MSK | Save
  • A multi-institutional evaluation of active surveillance for low risk prostate cancer
    Journal Article

    Eggener, S. E.; Mueller, A.; Berglund, R. K.; Ayyathurai, R.; Soloway, C.; Soloway, M. S.; Abouassaly, R.; Klein, E. A.; Jones, S. J.; Zappavigna, C.; more...
    Journal of Urology (2013)

    Fulltext@MSK | Save
  • Biomimetic diversity-oriented synthesis of benzannulated medium rings via ring expansion
    Journal Article

    Bauer, R. A.; Wenderski, T. A.; Tan, D. S.
    Nature Chemical Biology (2013)

    Fulltext@MSK | Save
  • Next-generation point-of-care immunoassay system for rapid and accurate determination of cancer markers in the physician office
    Meeting Abstract

    Zappala, S. M.; Libertino, J. A.; Wein, A. J.; Vaughan, E. D.; Scardino, P. T.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Targeting castration resistant prostate cancer (CRPC) with autologous PSMA-directed CAR plus T cells
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Olszewska, M.; Taylor, C.; Bartido, S.; Scher, H. I.; Sadelain, M.; Riviere, I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of the androgen signaling inhibitor ARN-509 in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Steinbrecher, J. E.; Arauz, G.; Curley, T.; Rix, P. J.; Maneval, E. C.; Chen, I.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • How well do we communicate risk? An evaluation of AJCC version 6 and 7 staging systems for soft tissue sarcomas
    Meeting Abstract

    Maki, R. G.; Antonescu, C. R.; Hameed, M.; Moraco, N. H.; Singer, S.; Brennan, M. F.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors (HSP90i)
    Meeting Abstract

    Jhaveri, K. L.; Iyengar, N. M.; Corben, A.; Patil, S.; Akram, M.; Towers, R.; Sakr, R.; Hudis, C.; King, T. A.; Rosen, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Effect of IL-22 on intestinal stem cells, GVHD-related tissue damage, and GVL
    Meeting Abstract

    Hanash, A. M.; Van Den Brink, M. R. M.; Hua, G.; Kolesnick, R.; Blazar, B. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save